Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training
Phase 2
Completed
- Conditions
- Gastrointestinal NeoplasmsBronchial CarcinomaHodgkin DiseaseNon-Hodgkin LymphomaWeight Loss
- Registration Number
- NCT00196885
- Lead Sponsor
- German Cancer Research Center
- Brief Summary
The purpose of the study is to tests the hypothesis, that N-acetylcysteine (a thiol-antioxidant)improves the exercise training effect on cancer patients that experience weight loss (cachexia) as assessed by muscle mass and function as well as histomorphology.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- gastrointestinal or bronchial cancer
- weight loss of 10% within 6 months
- sufficient mobility
Exclusion Criteria
- severe pain, steroid therapy, severe internal, muscular, neurological, psychiatric disease, N-acetylcysteine allergy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method muscle cross-sectional area, peak forces
- Secondary Outcome Measures
Name Time Method muscle fiber composition (biopsy vastus lateralis muscle mRNA levels of cytokines, myostatin. Activity of Akt-dependent pathways muscle 31Phospho-magnetic-resonance spectroscopy
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does N-acetylcysteine target to improve skeletal muscle histomorphology in cancer cachexia?
How does N-acetylcysteine compare to standard-of-care interventions for muscle function in cachectic cancer patients?
Which biomarkers correlate with improved muscle mass in NCT00196885 cachexia trials using antioxidants?
What adverse events are associated with N-acetylcysteine use in gastrointestinal neoplasms and cachexia patients?
Are there combination therapies involving N-acetylcysteine and resistance training for non-Hodgkin lymphoma cachexia?
Trial Locations
- Locations (1)
German Cancer Research Center, D020
🇩🇪Heidelberg, Baden-Württemberg, Germany
German Cancer Research Center, D020🇩🇪Heidelberg, Baden-Württemberg, Germany